Pedro C. Barata, Gary Tincknell, David Michael Gill, Simon Yuen Fai Fu, Aviral Singh, Alton Oliver Sartor, David Cade, Neeraj Agarwal. "Safety and dosimetry of 177 Lu-rosopatamab tetraxetanplus SoC in patients with metastatic castration-resistant prostate cancer: Preliminary results from part 1 of phase 3 ProstACT Global study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba5009